StonvexLoading…
StonvexStonvexStonvexCore line items from BC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.36B | $5.24B | $6.40B | $6.81B |
Operating Income | $-40.70M | $311.60M | $734.90M | $947.80M |
Net Income | $-137.30M | $130.10M | $420.40M | $677.00M |
EPS (Diluted) | $-2.08 | $1.93 | $5.96 | $9.00 |
Total Assets | $5.31B | $5.68B | $6.23B | $6.32B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $256.80M | $269.00M | $467.80M | $595.60M |
Free Cash Flow OCF − CapEx | $396.30M | $264.00M | $444.30M | $197.80M |
Shares Outstanding | 64.89M | 65.99M | 68.23M | 71.36M |